triptolide has been researched along with Glioblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appiani La Rosa, S; Kannan, RM; Liaw, K; Salazar, S; Sharma, A; Sharma, R | 1 |
1 other study(ies) available for triptolide and Glioblastoma
| Article | Year |
|---|---|
Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma.
Topics: Dendrimers; Diterpenes; Epoxy Compounds; Glioblastoma; Humans; Phenanthrenes; Tumor-Associated Macrophages | 2021 |